ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Clinical trial NCT01001377 · COMPLETED

Trial details

NCT number: NCT01001377
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2010-02-02
Primary completion: 2013-02-05
Enrollment: 1010

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.